arthritis in the elderly gerald f. falasca, m.d. johnson city, tn march 2013 “all the pearls in 50...
Post on 23-Dec-2015
214 Views
Preview:
TRANSCRIPT
Arthritis in the Arthritis in the ElderlyElderly
Gerald F. Falasca, M.D.
Johnson City, TN
March 2013March 2013
“All the Pearls in 50 Minutes”
GOALS
• Practical advice
• Up to date on mgt
• Hone diagnostic skills
DISEASESTo Be Touched On
• Sjogren’s
• PMR
• DJD
• RA
• Gout
CASE 1
• A 70 year old woman presents with widespread pain, stiffness and fatigue. She recently started keeping a water bottle at her bedside. Physical exam is remarkable for slight synovitis of hands & wrists, and presence of all fibromyalgia tender points.
CASE 1 – cont’d.
• Sed rate is 30 mm/hr but CRP is normal CRP at 0.7 mg/dl (nl 0 - 1.0 mg/dl)
• C4 ↑ at 36 mg/dl.
• RF, CCP & ANA are negative.
CASE 1 – cont’d.
What is the most likely diagnosis?
A. Polymyalgia rheumatica
B. Rheumatoid arthritis
C. Fibromyalgia
D. Primary Sjogren syndrome
E. Paraneoplastic syndrome
Causes of Pain All Over in the Elderly
• Polymyalgia rheumatica• Statins• Fibromyalgia• Depression• Sjogren’s• Rheumatoid• Lupus• Osteoarthritis
Primary Sjogren’s
• Dry eyes, dry mouth
• Fatigue
• Pain all over
• No idea what is wrong with them
• You probably have some in your practice
Sjogren’s - History
• Use of eye drops?
• Can you eat crackers w/o water?
• Keep water on night table?
• Physical Exam: Nothing specific!– Sometimes small joint puffiness– Peripheral neuropathy
Sjogren’s - Lab
• SSA / SSB – insensitive
• ESR often up
• CRP high normal
Sjogren’s - TX
• Hydroxychloroquine
• Low-dose prednisone
• Methotrexate
• Rituximab
• Fibromyalgia treatments (for symptoms)
Polymyalgia Rheumatica
• 10-15% go on to GCA• Respond well to treatment
• In other words, this is a potentially serious disease that is treatable.
PMR
• Pain all over; sudden onset.• Age > 50 (usually >70!)• Weight loss• Shoulder limitation of motion
(periarthritis)• Proximal muscle tenderness• Sed rate > 50 mm/hr• Anemia
PREDNISONE in ELDERLY
• ↓K+, ↑glucose
• DEXA
• Calcium + Vit D
• T/C bisphosphonate
• Eye exams: cataracts & pressure
Amer. College of Rheum.
• Recommendations for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis 2010
• Arthritis Care & Research, Vol. 62, No. 11, November 2010, pp 1515–1526
• DOI 10.1002/acr.20295
GOUT
The risk factors for gout were known to the
ancients.
Risk Factors for Gout
• Obesity, metabolic syndrome
• Ethanol
• Diuretics
• Fructose ingestion
• Excessive purine ingestion
Ben Franklin (1706 -1790)
"Be temperate in wine, in eating, girls, and sloth, or the Gout will seize you and plague you…"
-- Franklin
Drugs Associated with Hyperuricemia
• Diuretics (loop and thiazide types)
• Low-dose aspirin
• Ethanol
Hyperuricemia & Gout
Serum Uric Acid (mg/dl)
Annual Incidence of Gout (%)
< 7.0 0.1
7.0 – 8.9 0.5
> 9.0 4.9
This is chronic refractory
gout!
Amer. College of Rheum.
• Guidelines for Management of Gout. Part 1 & 2
• Arthritis Care & Research, Vol. 64, No. 10, October 2012, pp 1431–1461
• DOI 10.1002/acr.21773
The Three Phases of Gout Treatment
• Treat acute attack
• Prevent new attacks
• Reduce uric acid level (sometimes)
Phase 1 - Termination
• NSAID
• Colchcine
• Intra-articular steroids
• Systemic steroids
• IL-1 inhibitor (off-label use)
NSAIDs
• Treatment of choice in otherwise healthy (elderly?) patient.
• Avoid in renal insufficiency and in peptic ulcer disease.
• Avoid salicylates (these cause swings in serum uric acid).
Intra-Articular Steroids
• One or a few joints.
• Make sure infection not present.
Oral Colchicine
• 1.2 mg followed by 0.6 mg 2 hrs later.
• Loading dose same in renal insufficiency.
• Maintenance (preventive) dose 0.6 mg qd or bid.
• 0.3 mg 2-3 times per week in dialysis patients (preventive).
Systemic Steroids
• Polyarticular attacks or fever.
• Longstanding attacks (>3-5 days).
• Need divided doses.
• Taper over 7-10 days.
• Start prophylactic agent (colchicine) as soon as possible.
Adjunctive Measures
• Rest
• Ice
• Elevation
• Analgesics
• Anti-motility agents (if using colchicine or indomethacin)
• Continue hypouricemic agent if patient has been taking it.
Phase 2 - Preventive Therapy
• Colchicine or NSAID.• Always use when beginning a
hypouricemic drug.• Continue several weeks to years
(depending on tophi, serum uric acid).
• Always use before surgery in previously gouty patient.
Phase 3 - Hypouricemic Therapy
• Not every patient needs it.
• May not need it in:– Very elderly– Non-compliant– Infrequent attacks and no tophi
• May exacerbate attacks early on
Goals of Hypouricemic Treatment
• Aim for serum uric acid under 6, preferably near 5 for some chronic gouty patients.
• But remember:– allopurinol toxicity more likely with
higher dose.– More likely with renal insufficiency.
Hypouricemic Agents
• Allopurinol
• Febuxostat
• Probenecid
• Losartan (off-label)
• Vitamin C (off-label)
• Pegloticase
Major Toxicities of Allopurinol
• Increased gout attacks early on (use prophylaxis)
• Rash (may be severe)
• Stevens-Johnson syndrome
• Vasculitis
• Hepatitis
• Renal failure (interstitial nephritis)
• Bone marrow suppression
Allopurinol Hypersensitivity Syndrome
• Fever• Rash• Renal Failure
• Hepatic injury• Leukocytosis• Eosinophilia (the
tipoff!)
• May be fatal. Hard to treat.
• Serious reactions to allopurinol reported
in 1 of 260 patients. Arthritis Rheum 29:82, 1986
Febuxostat
• Non-xanthine inhibitor of XO and XD.
• Better tolerated than allopurinol.
• Lower uric acid levels than allopurinol (53% vs. 21% met target of 6.0 mg/dl).
• Better dissolution of tophi.
Tophus ReductionMean Reduction in Tophus Area
Becker MA. N Engl J Med. 2005 Dec 8;353(23):2450-61. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Group % Area Reduction P Value
Feb 80 mg 83 P = .08 (NS)
Feb 120 mg 66 P = 0.16 (NS)
Allop 300mg 50
Febuxostat vs. AllopurinolPercentage of Patients Achieving Serum
Uric Acid < 6 mg/dl
Study 1: Allopurinol dosed at 300 mg/d for ClCr ≥ 60 ml/min or 200 mg/d for 30 ≤ ClCr ≤ 59 ml/min.
Febuxostat: Best Use
• Allopurinol failures
• Renal insufficiency
• Tophaceous gout
Allopurinol & Febuxostat Drug Interactions
• Life threatening interaction with azathioprine, 6-mercaptopurine.– Reduce dose of purine analogue by
approximately 2/3.
• Theophylline
• Other interactions also
Gout vs. Pseudogout
• Gout– hallux, ankle, knee, hand– younger, male
• Pseudogout– knee, wrist, ankle– older, female
• Almost any joint can be affected by either disease!
CPPD Deposition
• Wrist: triangular ligament
• Pelvis: symphysis pubis
• Knee: menisci
• Also: annulus fibrosis, articular capsules, bursae, ligaments, tendons
Clinical Associations with Psuedogout
• Aging• Previous joint
surgery• Previous joint
trauma• Familial types• Gout• Amyloidosis
• Hyperpara• Hemochromatosis• Hypomagnesemia• Familial hypocalciuric
hypercalcemia• Hypophosphatasia• Wilson’s disease• Ochronosis
Pseudo-DJD Pattern of CPPD
• 50% of CPPD patients.
• Wrists, MCPs, elbows, shoulders, knees. Note difference from usual DJD pattern.
• Heberden’s or Bouchard’s frequently found.
• May be acute or chronic.
Treatment of Acute Psuedogout
• Aspiration (more important than in gout!)
• Rest
• Intra-articular steroids
• NSAIDs
• Systemic steroids
• Colchicine?
• IL-1 Inhibitors?
Pseudogout Prevention
• Colchicine
• NSAID
• Magnesium?
• There’s no allopurinol for pseudogout (unfortunately).
The Basic (Non-Acidic) Calcium Phosphates
• Hydroxyapatite
• Calcium carbonate
• Octacalcium phosphate
• Tricalcium phosphate (whitlockite)
• Hydroxyapatite is non-birefringent.
Syndromes Associated with Hydroxyapatite
• Acute monoarthritis (pseudopseudogout)
• Acute calcific tendinitis, bursitis
• Scleroderma, dermatomyositis
• Heterotopic calcification
• Milwaukee shoulder
• Crowned Dens Synd.
Acute Apatite Monoarthritis
(Pseudopseudogout)• Is usually a peri-arthritis.
• Intense inflammation (looks septic)
• Synovial fluid often non-inflammatory.
• Often causes podagra (especially in younger women).
• Look for the telltale calcifications on radiographs.
CROWNED DENS SYNDROME
Crowned Dens Synd
• Headache
• Pain with head rotation
• Shoulder myalgias
• Very elevated sed rate
RHEUMATOIDARTHRITIS
In the Elderly
Rheumatoid
• Even in the elderly, completely new paradigm of treatment.
• Dual goals:– Symptom improvement– Prevention of structural damage
Rheumatoid
• “Small joint polyarthritis with morning stiffness”
• MCPs, wrists, MTPs
• ESR, CRP may or may not be up.
• RF or anti-CCP pos 70%
RA in the Elderly
• M:F ratio more nearly equal
• More shoulder involvement
• May overlap with polymyalgia rheumatoica
Initial Tx of RA
• Low dose prednisone (actually a good DMARD!)
• Methotrexate – safer than we expected in 1987!– Lung toxicity is possible– Follow liver enzymes– Added infection risk is relatively low
(2-3%).
What We Try to Prevent
The New Paradigm
• Is it likely that the patient will have destructive or debilitating disease in the long-term?
• If so, begin one or more DMARDs (often MTX).
• If inadequate response after 3 months, add or switch DMARDs, often includes a TNFI.
Anti-CCP
• CCP = cyclic citrullinated peptides• RA synovium overproduces CCP• RA patients THEN make
ANTIBODIES to CCP• 70% sensitive, 90% specific• Anti-CCP is often present years
before RA manifests itself.
Goals of the New Criteria
• Identify persons with “early arthritis” who are at high risk of erosive or debilitating disease.
• Allow for earlier disease modifying treatment.
• But…the criteria are not simple!
2010 ACR/EULAR CRITERIA FOR CLASSIFICATION OF RHEUMATOID ARTHRITIS
Arthritis & Rheumatism 62(9): 2569–2581, 2010.
Lab Eval of Polyarthritis
• Rheum factor• Anti-CCP• ANA• C4• Lyme• CBC• Chem-12
• SSA, SSB• Anti-RNP
Methotrexate
• Standard of care for RA.• dihydrofolate reductase inhibitor.• Best initial treatment for most patients.• Avoid in pre-existing liver disease, renal
disease and in drinkers.• Main risk: pulmonary toxicity• Higher doses being used, espec. Sub Q.• 1/3 of patients will have little or no
radiographic progression on MTX alone.
Methotrexate (cont’d)
• Always give only once a week, but dose may be split in two parts, and given 12 hours apart.
• Most persons should receive supplemental folate 1 mg/d.
• Follow liver enzymes (with albumin), CBC, creatinine monthly initially.
Methotrexate - Side Effects
• Nausea, diarrhea• Stomatitis• Alopecia• Rash• Infections• MTX
pneumonitis
• Hepatitis• Cirrhosis• Pulm. fibrosis• Pancytopenia• Lymphoma?
• Don’t use if creatinine > 2.0!
TNF Inhibitors
• Potent inhibitors of inflammation
• Have revolutionized the treatment of RA since 1998.
• They retard erosions
• Act quickly
• Two approaches: monoclonal Ab vs. soluble receptor
• $$$$
Side Effects of TNF Inhibitors
• Rashes, especially inject. site rxns.• Infections.• Reactivation of tuberculosis.• Demyelinating disease, optic neuritis,
seizures.• Pancytopenia.• Congestive heart failure (effect may last
for months).• Malignancy (espec. lymphoma)
Prednisone
• Low dose prednisone: 7.5 mg/d
• Reduces number of erosions at two years in early RA (22% vs. 46%).
• N Engl J Med 1995 Jul 20;333(3):142-6.
Remission: The New Standard?
• Durable remissions are achievable with combination therapy.
• Definition of remission important however!
• Remission depends heavily on treating early (first year of disease)
• New trials may report the remission rate as the primary outcome measure
RA Take Home Messages
• The treatment paradigm has changed in the past 10-15 years.
• Aggressive treatment changes long-term outcome.
• The earlier treatment is started, the better.
• There are new tools to help us make an earlier diagnosis.
Osteoarthritis
• Everyone gets a little
• Minor degenerative changes on xray often meaningless
• Knee, 1st CMC, DIPs, hip, back
• Usually localized– Exception: Erosive or inflammatory
OA.
Nonpharmacologic Therapy for Patients with OA
Amer. Coll. Of Rheumatology
• Patient education Self-management programs (e.g., Arthritis Foundation Self-Management Program) Personalized social support through telephone contact Weight loss (if overweight) Aerobic exercise programs Physical therapy Range-of-motion exercises Muscle-strengthening exercises Assistive devices for ambulationPatellar tapingAppropriate footwear Lateral-wedged insoles (for genu varum) BracingOccupational therapyJoint protection and energy conservation Assistive devices for activities of daily living
http://www.rheumatology.org/practice/clinical/guidelines/oa-mgmt.asp
Pharmacologic Therapy for Patients with OA
Amer. Coll. Of Rheumatology
• Acetaminophen• COX-2-specific inhibitor• Nonselective NSAID [plus misoprostol or a
proton pump inhibitor if at ↑GI risk]• Non-acetylated salicylate• Other pure analgesics: Tramadol
• Opioids • Intraarticular glucocorticoids, hyaluronan
• Topical Capsaicin Methylsalicylate
http://www.rheumatology.org/practice/clinical/guidelines/oa-mgmt.asp
OA of the Knee
• Most sensitive and specific finding on physical exam:
• CREPITUS!CREPITUS!
• Sometimes knee pain is coming from the hip
OA of Knee
• Glucosamine: mixed data
• Corticosteroid injection
• Viscosupplementation
• Quadriceps exercises
• Neoprene sleeve
• Hinged brace
OA of the Hip Joint
• Mimicked by low back pain!
• Most common cause of trochanteric bursitis is low back pain too!
• Hip pain usually radiates to groin, not to the “hip”.
Hip OA
• Injections don’t last long and are not practical.
• Hip replacement is a good operation.
1st CMC Osteoarthritis
• Brace off-the-shelf
• Brace custom molded
• Surgery
• Liniment
NSAIDsToxicity in Elderly
• Peptic ulcer disease
• Hypertension
• Congestive heart failure
• CNS changes
• Intestinal ulceration
GI Less Toxic NSAIDs
• Celecoxib
• Salsalate
• Meloxicam
• Nabumetone
• Etodolac
Risk Factors for UGI EventsAmer. Coll. Of Rheumatology
• Age >=65• Comorbid medical conditions• Oral glucocorticoids• History of peptic ulcer disease• History of upper gastrointestinal
bleeding • Anticoagulants
http://www.rheumatology.org/practice/clinical/guidelines/oa-mgmt.asp
RISK FACTORS FOR ULCERS
• NSAID Use• Age > 64• Prior event• CHF• Ethanol• Warfarin• Concomitant corticosteroid, low
dose aspirin, bisphosphonate, SSRI
• H. pylori
Ann Rheum Dis. 2007 March; 66(3): 417–418.
PREVALENCE OF NSAID ULCERS BY AGE
PREVENTION OF NSAID ULCERS
Arch Intern Med. 2002 Jan 8;162(2):169-75
NSAID ULCER PROPHYLAXIS
• H2 blockers NOT recommended for prophylaxis
• PPI or misoprostol recommended• PPI doesn’t seem to reduce
celecoxib ulcer complications further.
• Low dose aspirin ELIMINATES any benefit of celecoxib.
Amer. Coll. Of Gastro. 2009
• Patients with hx PUD should be tested for H. pylori prior to NSAID or ASA use.
Amer. Coll. Gastro. Guide. 2009
GI RISK
CV
RISK*
High Mod Low
High No NSAID, no COX-2
Naproxen + (PPI or MIS)
Naproxen + (PPI or MIS)
Low COX-2 + (PPI or MIS)
COX-2 or (NSAID + (PPI or MIS))
NSAID alone
*High CV risk defined as those needing aspirin therapy.
Prophylactic Regimens
• Misoprostol 200 mcg QID
• Lansoprazole 15 or 30 mg/d
• Esomeprazole 20 or 40 mg/d
CV Risk - Celecoxib
• 33 months Abs %RR
• Placebo 6/676 0.9% 1.0
• 200 mg BID 18/683 2.6%2.6
• 400 mg BID 23/669 3.4%3.4
N Engl J Med. 2006;355(9):873.
top related